ada guidelines dpp4 and glp 1 Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1 DPP-4 Inhibitors and the Quest

Furthermore, GLP-1 regulates weight and satiety and delays gastric emptying (Gutniak et al., 1992

Protocol 2: Companion to GLP-1 medication Goal: Reduce GLP-1 medication side effects and support gut health during treatment

New GLP-1 medications on the horizon The GLP-1 receptor agonist space is evolving rapidly

Gaspari T, Liu H, Welungoda I, Hu Y, Widdop RE, Knudsen LB, Simpson RW, Dear AE

Zhang C, Kaye JA, Cai Z, Wang Y, Prescott SL, Liberles SD

This phase often includes: Managing side effects such as nausea, constipation or low appetite Adjusting intake to support energy, metabolism, and muscle preservation Problem-solving around real-life situations like travel, stress, or schedule changes Ongoing support: adapting for real life As progress continues, visits are typically spaced out and focused on maintaining consistency over time